RIVOCERANIB for Hepatocellular carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where RIVOCERANIB was used for Hepatocellular carcinoma.
Most Reported Side Effects for RIVOCERANIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 28 | 40.6% | 2 | 17 |
| Thrombocytopenia | 13 | 18.8% | 1 | 3 |
| Nausea | 11 | 15.9% | 1 | 3 |
| Off label use | 10 | 14.5% | 1 | 3 |
| Anaemia | 9 | 13.0% | 1 | 1 |
| Hypertension | 9 | 13.0% | 0 | 0 |
| Neutropenia | 9 | 13.0% | 0 | 1 |
| Leukopenia | 8 | 11.6% | 0 | 1 |
| Vomiting | 8 | 11.6% | 1 | 2 |
| Diarrhoea | 7 | 10.1% | 0 | 1 |
| Hypothyroidism | 7 | 10.1% | 0 | 0 |
| Pneumonia | 7 | 10.1% | 3 | 4 |
| Rash | 6 | 8.7% | 0 | 0 |
| Decreased appetite | 5 | 7.3% | 0 | 2 |
| Fatigue | 5 | 7.3% | 0 | 1 |
Other Indications for RIVOCERANIB
Other Drugs Used for Hepatocellular carcinoma
ATEZOLIZUMAB (8,443)
BEVACIZUMAB (7,773)
LENVATINIB (5,384)
SORAFENIB (4,986)
CABOZANTINIB S-MALATE (2,670)
DURVALUMAB (1,255)
NIVOLUMAB (1,142)
REGORAFENIB (1,050)
TREMELIMUMAB\TREMELIMUMAB-ACTL (589)
PEMBROLIZUMAB (518)